- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05998538
Patients With Higher BMI Produces More Postoperative Drainage Volume and Length of Stay in Cross-Sectional Study
August 16, 2023 updated by: Ludwig Andre Pontoh, Indonesia University
Patients With Higher BMI Produces More Postoperative Drainage Volume and Longer Length of Stay in Cross-Sectional Study: a Comparison of Total vs Partial Knee Arthroplasty
Partial knee arthroplasty theoretically produces less blood loss compared to total knee arthroplasty (TKA) due to a lesser invasive procedure.
Medial unicompartmental knee arthroplasty (UKA) is the most common partial knee arthroplasty performed due used due to the most commonly impacted medial knee.
This study compared the postoperative drainage volume and length of stay (LOS) of TKA vs UKA and evaluated its comparison with patient characteristics.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Theoretically, UKA will produce less blood loss due to a shorter skin incision, quadriceps sparing muscle approach, persistence of cruciate ligaments, and less femorotibial dislocation.7
However, studies investigating drainage volume in UKA are still limited.
In this study, we compared the drainage volume of patients undergoing TKA vs UKA and evaluated several parameters that contributed the production.
This study has not received any funding or grant.
Study Type
Observational
Enrollment (Actual)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jakarta, Indonesia
- Pondok Indah Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
medical records of patients who underwent primary TKA and UKA between December 2019 and October 2022
Description
Inclusion Criteria:
- grade 4 Osteoarthritis
Exclusion Criteria:
- previous trauma
- infection
- blood coagulation disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
TKA (Total Knee Arthroplasty) procedure
Total Knee Arthroplasty
|
Total vs Partial Knee Replacement
|
|
UKA (Uni Knee Arthroplasty) procedure
Uni Knee Arthroplasty
|
Total vs Partial Knee Replacement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drainage Volume
Time Frame: 3-5 days post op
|
total drainage volume
|
3-5 days post op
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
LOS
Time Frame: pre-op until drainage removed, 3-6 days post op
|
length of stay
|
pre-op until drainage removed, 3-6 days post op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Ismail H Dilogo, Prof, Indonesia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 23, 2019
Primary Completion (Actual)
October 21, 2022
Study Completion (Actual)
December 7, 2022
Study Registration Dates
First Submitted
August 9, 2023
First Submitted That Met QC Criteria
August 16, 2023
First Posted (Actual)
August 21, 2023
Study Record Updates
Last Update Posted (Actual)
August 21, 2023
Last Update Submitted That Met QC Criteria
August 16, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23082020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.